Publications by authors named "G J Romeijn"
Article Synopsis
- The study examines the long-term effectiveness and safety of dupilumab, a treatment for atopic dermatitis (AD), in a diverse group of patients over a period of up to 5 years.
- Conducted in the Netherlands using the BioDay registry, the research includes 1,286 patients of different age groups receiving dupilumab between 2017 and 2022, with outcomes evaluated using various clinical measures.
- Results show that a majority of patients maintained controlled AD symptoms, with high levels of treatment effectiveness observed over time, and factors for treatment discontinuation were also assessed.
Background: The Recap of atopic eczema questionnaire (RECAP) was developed to measure eczema control in patients with atopic dermatitis (AD). The measurement properties of RECAP have not yet been validated in caregivers of children with AD.
Objectives: To assess the construct validity, responsiveness, reliability and interpretability of the Dutch proxy version of RECAP.
Background: Increased Staphylococcus aureus (SA) colonization is considered an important factor in the pathogenesis of atopic dermatitis (AD). Antibacterial therapeutic clothing aims to reduce SA colonization and AD inflammation; however, its role in the management of AD remains poorly understood.
Objectives: To investigate the effectiveness of antibacterial therapeutic clothing + standard topical treatment in patients with moderate-to-severe AD vs.
Article Synopsis
- Limited research has been conducted on the validity and reliability of the Recap of atopic eczema (RECAP) questionnaire, particularly its interpretability for adults with atopic dermatitis (AD).
- A study involving 200 adult participants aimed to assess the validity, reliability, and responsiveness of the Dutch RECAP by collecting data at multiple time points and comparing results with established reference instruments.
- The findings indicated that 82% of hypotheses regarding single-score validity were confirmed, and the RECAP effectively differentiated between varying degrees of disease severity, with established score bands to interpret eczema control levels.
Chronic hand eczema in Europe: Patient experiences and perspectives (CHEPEP) in qualitative interviews.
J Eur Acad Dermatol Venereol
July 2023
Background: Chronic hand eczema (CHE) is a very common skin disease among the European population. It causes itch and pain and, in more severe cases, seriously impairs hand functioning at work and in private life.
Objectives: To explore perspectives of people with lived experience on CHE-related problems, wishes and goals.